• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名台湾进行性骨化性纤维发育不良患者ACVR1基因出现新生617G-A核苷酸突变。

De novo 617G-A nucleotide mutation in the ACVR1 gene in a Taiwanese patient with fibrodysplasia ossificans progressiva.

作者信息

Lin Gau-Tyan, Chang Hsueh-Wei, Liu Chih-Shan, Huang Peng-Ju, Wang Hsien-Chung, Cheng Yuh-Min

机构信息

Faculty of Department of Orthopaedic Surgery, Chung-Ho Memorial Kaohsiung Medical University Hospital, Kaohsiung Medical University, No.100, Tzyou 1st road, Kaohsiung, 807, Taiwan, R.O.C..

Faculty of Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan, R.O.C..

出版信息

J Hum Genet. 2006;51(12):1083-1086. doi: 10.1007/s10038-006-0069-2. Epub 2006 Nov 1.

DOI:10.1007/s10038-006-0069-2
PMID:17077940
Abstract

Fibrodysplasia ossificans progressiva (FOP) is a rare congenital disease with autosomal dominant transmission characterized by the presence of malformations of the big toes and of postnatal progressive heterotopic endochondral osteogenesis. We report the case of 3-year-old girl with dysplasia of the first metatarsal bones and progressive heterotopic ossificans of the right thigh due to previous diphtheria-tetanus-pertussis immunizations and several inappropriate surgical interventions. Direct sequence analysis identified a 617G-A nucleotide mutation in the patient but not in her parents or brother. Pedigree analysis suggests that a de novo mutation in the ACVR1 gene is responsible for the disease in this family. This is the first report of the results of a mutation analysis in a sporadic case of FOP in a Taiwanese patient.

摘要

进行性骨化性纤维发育不良(FOP)是一种罕见的常染色体显性遗传性先天性疾病,其特征为大脚趾畸形以及出生后进行性异位软骨内成骨。我们报告了一名3岁女童的病例,她因之前接种白喉-破伤风-百日咳疫苗及多次不恰当的手术干预,出现第一跖骨发育异常和右大腿进行性异位骨化。直接测序分析在患者中发现了617G-A核苷酸突变,但其父母和兄弟未发现该突变。家系分析表明,ACVR1基因的新发突变是该家族中导致该疾病的原因。这是台湾地区一名散发性FOP患者突变分析结果的首次报告。

相似文献

1
De novo 617G-A nucleotide mutation in the ACVR1 gene in a Taiwanese patient with fibrodysplasia ossificans progressiva.一名台湾进行性骨化性纤维发育不良患者ACVR1基因出现新生617G-A核苷酸突变。
J Hum Genet. 2006;51(12):1083-1086. doi: 10.1007/s10038-006-0069-2. Epub 2006 Nov 1.
2
[A Chinese girl with fibrodysplasia ossificans progressiva caused by a de novo mutation R206H in ACVR1 gene].一名因ACVR1基因新发R206H突变导致进行性骨化性纤维发育不良的中国女孩
Zhonghua Er Ke Za Zhi. 2008 Mar;46(3):215-9.
3
A unique case of fibrodysplasia ossificans progressiva with an ACVR1 mutation, G356D, other than the common mutation (R206H).一例独特的进行性骨化性纤维发育不良病例,其携带ACVR1基因的G356D突变,而非常见的R206H突变。
Am J Med Genet A. 2008 Feb 15;146A(4):459-63. doi: 10.1002/ajmg.a.32151.
4
Fibrodysplasia ossificans progressiva with minor unilateral hallux anomaly in a sporadic case from Northern Tanzania with the common ACVR1c.617G>A mutation.来自坦桑尼亚北部的一例散发型进行性骨化性纤维发育不良病例,伴有轻微单侧拇趾异常,携带常见的ACVR1基因c.617G>A突变。
Pan Afr Med J. 2015 Nov 24;22:299. doi: 10.11604/pamj.2015.22.299.8032. eCollection 2015.
5
The ACVR1 617G>A mutation is also recurrent in three Japanese patients with fibrodysplasia ossificans progressiva.ACVR1基因617G>A突变在三名日本进行性骨化性纤维发育不良患者中也反复出现。
J Hum Genet. 2007;52(5):473-475. doi: 10.1007/s10038-007-0128-3. Epub 2007 Mar 10.
6
ACVR1 gene mutations in four Turkish patients diagnosed as fibrodysplasia ossificans progressiva.在四名被诊断为进行性骨化性纤维发育不良的土耳其患者中发现了 ACVR1 基因突变。
Gene. 2013 Feb 25;515(2):444-6. doi: 10.1016/j.gene.2012.12.005. Epub 2012 Dec 20.
7
ACVR1 gene mutation in sporadic Korean patients with fibrodysplasia ossificans progressiva.散发性韩国进行性骨化性纤维发育不良患者的ACVR1基因突变
J Korean Med Sci. 2009 Jun;24(3):433-7. doi: 10.3346/jkms.2009.24.3.433. Epub 2009 Jun 12.
8
Mutations of the noggin (NOG) and of the activin A type I receptor (ACVR1) genes in a series of twenty-seven French fibrodysplasia ossificans progressiva (FOP) patients.对27名法国进行性骨化性纤维发育不良(FOP)患者的骨形态发生蛋白拮抗剂(NOG)基因和激活素A I型受体(ACVR1)基因进行突变分析。
Genet Couns. 2009;20(1):53-62.
9
Rarely occurring mutation of ACVR1 gene in Moroccan patient with fibrodysplasia ossificans progressiva.摩洛哥进行性骨化性纤维发育不良患者中 ACVR1 基因罕见突变。
Clin Rheumatol. 2010 Jan;29(1):119-21. doi: 10.1007/s10067-009-1283-z. Epub 2009 Oct 1.
10
A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva.骨形态发生蛋白I型受体ACVR1中的复发性突变会导致遗传性和散发性进行性骨化性纤维发育不良。
Nat Genet. 2006 May;38(5):525-7. doi: 10.1038/ng1783. Epub 2006 Apr 23.

引用本文的文献

1
Palovarotene (Sohonos), a synthetic retinoid for reducing new heterotopic ossification in fibrodysplasia ossificans progressiva: history, present, and future.帕罗维罗汀(Sohonos),一种用于减少进行性骨化性纤维发育不良中新生异位骨化的合成维甲酸:历史、现状与未来。
JBMR Plus. 2024 Nov 19;9(1):ziae147. doi: 10.1093/jbmrpl/ziae147. eCollection 2025 Jan.
2
Immunologic Aspects in Fibrodysplasia Ossificans Progressiva.进行性骨化性纤维发育不良的免疫学方面。
Biomolecules. 2024 Mar 16;14(3):357. doi: 10.3390/biom14030357.
3
Macrophages in heterotopic ossification: from mechanisms to therapy.

本文引用的文献

1
A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva.骨形态发生蛋白I型受体ACVR1中的复发性突变会导致遗传性和散发性进行性骨化性纤维发育不良。
Nat Genet. 2006 May;38(5):525-7. doi: 10.1038/ng1783. Epub 2006 Apr 23.
2
The natural history of heterotopic ossification in patients who have fibrodysplasia ossificans progressiva. A study of forty-four patients.进行性骨化性纤维发育不良患者异位骨化的自然病史。一项对44例患者的研究。
J Bone Joint Surg Am. 1993 Feb;75(2):215-9. doi: 10.2106/00004623-199302000-00008.
3
A three generation family with fibrodysplasia ossificans progressiva.
异位骨化中的巨噬细胞:从机制到治疗
NPJ Regen Med. 2021 Oct 26;6(1):70. doi: 10.1038/s41536-021-00178-4.
4
ACVR1 Function in Health and Disease.ACVR1 在健康和疾病中的作用。
Cells. 2019 Oct 31;8(11):1366. doi: 10.3390/cells8111366.
5
Phenotypic differences of patients with fibrodysplasia ossificans progressive due to p.Arg258Ser variants of ACVR1.由ACVR1基因的p.Arg258Ser变异导致的进行性骨化性纤维发育不良患者的表型差异。
Hum Genome Var. 2015 Dec 10;2:15055. doi: 10.1038/hgv.2015.55. eCollection 2015.
6
Mutation Detection in Activin A Receptor, Type I (ACVR1) Gene in Fibrodysplasia Ossificans Progressiva in An Iranian Family.纤维性骨发育不良伴进行性骨化症中激活素 A 受体,Ⅰ型(ACVR1)基因突变的检测-伊朗一家系报道
Cell J. 2014 Feb 3;16(1):91-4.
7
Multipotent progenitors resident in the skeletal muscle interstitium exhibit robust BMP-dependent osteogenic activity and mediate heterotopic ossification.存在于骨骼肌间质中的多能祖细胞表现出强大的 BMP 依赖性成骨活性,并介导异位骨化。
J Bone Miner Res. 2012 May;27(5):1004-17. doi: 10.1002/jbmr.1562.
8
A novel ACVR1 mutation in the glycine/serine-rich domain found in the most benign case of a fibrodysplasia ossificans progressiva variant reported to date.迄今为止报道的最良性纤维发育不良性骨化进展变异病例中,在甘氨酸/丝氨酸丰富区发现了一种新型的 ACVR1 突变。
Bone. 2011 Mar 1;48(3):654-8. doi: 10.1016/j.bone.2010.10.164. Epub 2010 Oct 29.
9
Rarely occurring mutation of ACVR1 gene in Moroccan patient with fibrodysplasia ossificans progressiva.摩洛哥进行性骨化性纤维发育不良患者中 ACVR1 基因罕见突变。
Clin Rheumatol. 2010 Jan;29(1):119-21. doi: 10.1007/s10067-009-1283-z. Epub 2009 Oct 1.
10
ACVR1 gene mutation in sporadic Korean patients with fibrodysplasia ossificans progressiva.散发性韩国进行性骨化性纤维发育不良患者的ACVR1基因突变
J Korean Med Sci. 2009 Jun;24(3):433-7. doi: 10.3346/jkms.2009.24.3.433. Epub 2009 Jun 12.
一个患有进行性骨化性纤维发育不良的三代家族。
J Med Genet. 1993 Aug;30(8):687-9. doi: 10.1136/jmg.30.8.687.
4
Genetic transmission of fibrodysplasia ossificans progressiva. Report of a family.进行性骨化性纤维发育不良的遗传传递。一家系报告。
J Bone Joint Surg Am. 1993 Aug;75(8):1214-20. doi: 10.2106/00004623-199308000-00011.
5
Age- and joint-specific risk of initial heterotopic ossification in patients who have fibrodysplasia ossificans progressiva.进行性骨化性纤维发育不良患者初始异位骨化的年龄和关节特异性风险。
Clin Orthop Relat Res. 1994 Apr(301):243-8.
6
Permanent heterotopic ossification at the injection site after diphtheria-tetanus-pertussis immunizations in children who have fibrodysplasia ossificans progressiva.进行性骨化性纤维发育不良患儿在接种白喉-破伤风-百日咳疫苗后注射部位出现永久性异位骨化。
J Pediatr. 1995 May;126(5 Pt 1):762-4. doi: 10.1016/s0022-3476(95)70408-6.
7
The histopathology of fibrodysplasia ossificans progressiva. An endochondral process.进行性骨化性纤维发育不良的组织病理学。软骨内成骨过程。
J Bone Joint Surg Am. 1993 Feb;75(2):220-30. doi: 10.2106/00004623-199302000-00009.
8
Fibrodysplasia ossificans progressiva. The clinical features and natural history of 34 patients.进行性骨化性纤维发育不良。34例患者的临床特征及自然病史。
J Bone Joint Surg Br. 1982;64(1):76-83. doi: 10.1302/0301-620X.64B1.7068725.